Drug delivery, formulation

108 Results

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Resupply Optimization through IRT and the Benefits of a Drug Supply Center of Excellence

Cenduit | Recorded the 31-Jan-2019 | Webinar

This case study will discuss the many challenges of re-supply optimization

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Survey Report: State of the global pharmaceutical contract services industry 2018

William Reed | 11-Jul-2018 | Research Study

In May 2018 Outsourcing-Pharma.com, in association with InnovoCommerce, conducted its second annual ‘state of the industry’ survey on its user base of...

Marken Delivers Compassionate Use Dose of Emergency Medication to Critical Pediatric Patient

Marken: Global Life Science Supply Chain Solutions | 26-Jun-2018 | Case Study

A desperate mother in Germany urged her team of doctors to reach out to a Marken client on behalf of her two year old girl. The child was battling leukemia...

Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

A Case Study of the Development, Technical Transfer, and Scale-Up of a Lyophilized Antibody-Drug Conjugate Formulation

Baxter BioPharma Solutions | Recorded the 01-Jun-2017 | Webinar

Antibody-drug conjugates (ADCs) were developed to target the delivery of chemotherapeutic agents and greatly reduce the quantity of chemotherapeutic agent...

BEPO, the enabling technology to long-acting injectable adoption

MEDINCELL | Recorded the 20-Apr-2017 | Webinar

Already in clinical stage, BEPO is MedinCell proprietary long-acting injectable (LAI) platform based on a combination of copolymers, solvent and active...